Veritas Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $416M | Sell |
845,995
-287,874
| -25% | -$156M | 7.04% | 8 |
|
|
2025
Q4 | $657M | Sell |
1,133,869
-84,236
| -7% | -$47.6M | 6.72% | 7 |
|
|
2025
Q3 | $591M | Sell |
1,218,105
-45,342
| -4% | -$21.1M | 6.31% | 7 |
|
|
2025
Q2 | $512M | Sell |
1,263,447
-69,605
| -5% | -$29.1M | 5.13% | 9 |
|
|
2025
Q1 | $663M | Buy |
1,333,052
+305,893
| +30% | +$166M | 6.7% | 7 |
|
|
2024
Q4 | $534M | Sell |
1,027,159
-103,317
| -9% | -$56.8M | 4.98% | 10 |
|
|
2024
Q3 | $699M | Sell |
1,130,476
-18,050
| -2% | -$10.7M | 5.17% | 9 |
|
|
2024
Q2 | $635M | Sell |
1,148,526
-541,715
| -32% | -$310M | 4.81% | 10 |
|
|
2024
Q1 | $982M | Sell |
1,690,241
-1,907
| -0.1% | -$1.07M | 7.13% | 6 |
|
|
2023
Q4 | $898M | Buy |
1,692,148
+697,383
| +70% | +$338M | 6.47% | 7 |
|
|
2023
Q3 | $504M | Sell |
994,765
-15,346
| -2% | -$8.18M | 3.79% | 13 |
|
|
2023
Q2 | $527M | Buy |
1,010,111
+1,656
| +0.2% | +$894K | 3.67% | 13 |
|
|
2023
Q1 | $581M | Sell |
1,008,455
-8,211
| -0.8% | -$4.63M | 4.29% | 11 |
|
|
2022
Q4 | $560M | Sell |
1,016,666
-50,742
| -5% | -$26.9M | 4.58% | 10 |
|
|
2022
Q3 | $541M | Buy |
1,067,408
+342,924
| +47% | +$192M | 4.48% | 12 |
|
|
2022
Q2 | $394M | Sell |
724,484
-13,820
| -2% | -$7.61M | 2.94% | 15 |
|
|
2022
Q1 | $436M | Buy |
738,304
+6,700
| +0.9% | +$3.85M | 2.67% | 15 |
|
|
2021
Q4 | $488M | Sell |
731,604
-718,400
| -50% | -$449M | 2.74% | 16 |
|
|
2021
Q3 | $828M | Sell |
1,450,004
-5,893
| -0.4% | -$3.23M | 4.75% | 10 |
|
|
2021
Q2 | $734M | Sell |
1,455,897
-103,600
| -7% | -$48.9M | 4.12% | 12 |
|
|
2021
Q1 | $712M | Buy |
1,559,497
+9,027
| +0.6% | +$4.31M | 3.9% | 15 |
|
|
2020
Q4 | $722M | Sell |
1,550,470
-3,600
| -0.2% | -$1.69M | 4.31% | 13 |
|
|
2020
Q3 | $686M | Sell |
1,554,070
-267,011
| -15% | -$110M | 4.76% | 12 |
|
|
2020
Q2 | $660M | Sell |
1,821,081
-15,451
| -0.8% | -$5.18M | 4.83% | 13 |
|
|
2020
Q1 | $521M | Sell |
1,836,532
-824,800
| -31% | -$260M | 4.14% | 14 |
|
|
2019
Q4 | $865M | Sell |
2,661,332
-17,895
| -0.7% | -$5.43M | 7.41% | 4 |
|
|
2019
Q3 | $780M | Sell |
2,679,227
-42,400
| -2% | -$12.1M | 7.6% | 4 |
|
|
2019
Q2 | $799M | Sell |
2,721,627
-195,100
| -7% | -$53.7M | 6.82% | 6 |
|
|
2019
Q1 | $798M | Sell |
2,916,727
-787
| -0% | -$196K | 7.18% | 2 |
|
|
2018
Q4 | $653M | Sell |
2,917,514
-218,045
| -7% | -$51.2M | 6.05% | 5 |
|
|
2018
Q3 | $765M | Sell |
3,135,559
-89,900
| -3% | -$20.7M | 6.44% | 4 |
|
|
2018
Q2 | $668M | Sell |
3,225,459
-259,800
| -7% | -$55.1M | 5.48% | 9 |
|
|
2018
Q1 | $720M | Sell |
3,485,259
-41,900
| -1% | -$8.79M | 5.82% | 5 |
|
|
2017
Q4 | $670M | Buy |
3,527,159
+23,900
| +0.7% | +$4.58M | 5.2% | 10 |
|
|
2017
Q3 | $663M | Buy |
3,503,259
+1,072,500
| +44% | +$194M | 5.42% | 9 |
|
|
2017
Q2 | $424M | Buy |
2,430,759
+1,286,259
| +112% | +$216M | 3.31% | 16 |
|
|
2017
Q1 | $176M | Buy |
+1,144,500
| New | +$175M | 1.59% | 18 |
|
Other funds holding TMO
VCM
Veritas Asset Management's TMO Position: Q1 2026 in Review
Veritas Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 25% in Q1 2026, selling an estimated $156M and leaving 845,995 shares worth $416M. The position accounts for 7.04% of the portfolio, ranked #8.
Veritas Asset Management first reported a position in TMO in Q1 2017 and has held it in 37 quarters since. The position peaked at $982M in Q1 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Veritas Asset Management held 845,995 shares of Thermo Fisher Scientific worth $416M as of Q1 2026.
- Veritas Asset Management sold 287,874 Thermo Fisher Scientific shares in Q1 2026, an estimated $156M.
- Thermo Fisher Scientific made up 7.04% of Veritas Asset Management's portfolio in Q1 2026, its #8 holding.
- Veritas Asset Management first reported a position in Thermo Fisher Scientific in Q1 2017 and has held it in 37 quarters since.
- Veritas Asset Management's Thermo Fisher Scientific position peaked at $982M in Q1 2024.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Veritas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.